< Back to previous page
Researcher
Peter de Witte
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Molecular Biodiscovery (Division)
Responsible
From1 Apr 2013 → Today - Molecular Biodiscovery (Division)
Member
From1 Apr 2013 → Today
Projects
11 - 20 of 31
- Zebrafish platform for neuroactive drug discovery and safety assessmentFrom1 Jan 2019 → 31 Dec 2020Funding: IOF - technology validation in lab
- Unraveling the susceptibility and pathogenesis of viral infections using zebrafishFrom1 Oct 2018 → 30 Sep 2022Funding: BOF - Concerted Research Project from 1994
- Use of fluorescent probes to study pharmacokinetics in zebrafish (Danio rerio) embryos and larvaeFrom12 Dec 2017 → 19 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Development of compounds for the treatment of drug resistant epilepsyFrom14 Nov 2017 → 31 Dec 2022Funding: FWO Strategic Basic Research Grant, BOF - Doctoral projects
- Towards an efficient treatment of drug-resistant epilepsyFrom1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- Deciphering the role of a novel endoplasmic reticulum associated protein complex in inter-organellar communication and calcium fluxesFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
- Discovery of Antiseizure Compounds in Zebrafish Models for the Treatment of Drug-Resistant EpilepsyFrom15 Nov 2016 → 9 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Improving the flow in the pipeline of the next generation of marine biodiscovery scientistsFrom1 Nov 2016 → 31 Oct 2020Funding: H2020 - Skills and Career Development (Marie Skłodowska-Curie) actions
- Zebrafish platform for drug discovery and safety testingFrom1 Jan 2016 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
- Modeling Renal Fibrosis in Zebrafish Using Aristolochic Acid IFrom13 Oct 2015 → 20 Aug 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 146
- Detailed comparison of in-house developed and commercially available heart-cutting and selective comprehensive two-dimensional liquid chromatography systems(2024)
Authors: Peter de Witte, Deirdre Cabooter
- New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived Micromonospora Strains(2023)
Authors: Peter de Witte
- Electrochemical degradation of 17α-ethinylestradiol: Transformation products, degradation pathways and in vivo assessment of estrogenic activity(2023)
Authors: Peter de Witte, Deirdre Cabooter
- Optimizing transfer and dilution processes when using active solvent modulation in on-line two-dimensional liquid chromatography(2023)
Authors: Soraya Chapel, Peter de Witte, Deirdre Cabooter
- The Role of Histo-Blood Group Antigens and Microbiota in Human Norovirus Replication in Zebrafish Larvae(2022)
Authors: Arno Cuvry, Dufie Strubbe, Johan Neyts, Peter de Witte, Joana Duarte Da Rocha Pereira
- Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptor(2022)
Authors: Aleksandra Siekierska, Peter de Witte, Daniëlle Copmans
- Hyperactivation of mTORC1 in a double hit mutant zebrafish model of tuberous sclerosis complex causes increased seizure susceptibility and neurodevelopmental abnormalities(2022)
Authors: Ann-Sofie De Meulemeester, Lise Heylen, Aleksandra Siekierska, Peter de Witte
- Modeling mTORopathies in zebrafish(2022)
Authors: Ann-Sofie De Meulemeester, Peter de Witte, Lieven Lagae
- Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction(2022)
Authors: Isabelle Adant, Bram Decru, Peter de Witte, Daisy Rymen, Peter Witters, Pieter Vermeersch, David Cassiman, Bart Ghesquière
- Development of compounds for the treatment of drug-resistant epilepsies(2022)
Authors: Gert Steurs, Wim De Borggraeve, Peter de Witte
Patents
1 - 10 of 10
- Treatment of pharmacoresistant epilepsy (Inventor)
- Idebenone in the treatment of drug resistant epilepsy (Inventor)
- Treatment of epilepsy (Inventor)
- Treatment of epilepsy (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy (Inventor)
- Anticonvulsant activity of bisabolene sesquiterpenoids isolated from turmeric oil (Inventor)
- Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids (Inventor)